Tyra Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tyra Biosciences, Inc. (TYRA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents91.9758.01251.21302.1815.22
Short-Term Investments249.48145.460.000.000.00
Cash & Short-Term Investments341.44203.47251.21302.1815.22
Accounts Receivable2.000.700.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets4.028.206.081.880.06
Total Current Assets347.46211.67257.29304.0615.28
Non-Current Assets
Property, Plant & Equipment (Net)7.728.153.542.090.47
Other Non-Current Assets8.386.035.350.560.26
Total Non-Current Assets16.1014.198.892.640.00
Total Assets363.56225.86266.18306.7016.01
Current Liabilities
Accounts Payable0.594.661.150.550.66
Short-Term Debt0.410.000.000.000.00
Accrued Liabilities13.5910.394.422.861.05
Other Current Liabilities13.590.000.000.000.00
Total Current Liabilities14.5915.335.703.621.86
Non-Current Liabilities
Long-Term Debt5.816.222.480.980.00
Other Non-Current Liabilities0.000.050.170.370.14
Total Non-Current Liabilities5.816.262.651.350.00
Total Liabilities20.4121.608.354.962.00
Stockholders' Equity
Common Stock0.010.000.000.000.00
Retained Earnings-251.31-164.83-95.70-40.37-14.08
Accumulated Other Comprehensive Income0.770.380.000.000.00
Additional Paid-in Capital593.69368.71353.52342.100.00
Shares Outstanding50.7543.0242.3541.440.00
Total Stockholders' Equity343.15204.26257.83301.7414.01
Total Liabilities & Equity363.56225.86266.18306.700.00